Including foods rich in Vitamin C, such as citrus fruits, berries, kiwi, and leafy greens, can help meet the recommended daily intake, suggests Dr Prasad Kuvalekar.
A meeting of the board of directors of GlaxoSmithkline Consumer Healthcare Ltd is scheduled on January 31, 2003, inter alia, to consider and adopt the audited financial results for the year ended December 31, 2002.\n\n\n\n
Modi inaugurated the Semicon India 2025 in Delhi, in the presence of Chief Minister Rekha Gupta, and Union Minister of Commerce and Industry Jitin Prasada.
Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.
'We remain cautious in this environment, and the uncertainty continues.'
rediffGURU Nayagam PP, career counsellor and the founder of EduJob360, counsels students and aspiring professionals about how they can make the right career decision.
Stock markets snapped the four-day falling streak on Tuesday with the benchmark Sensex rebounding by 317 points on buying in auto and pharma shares amid a decline in retail inflation to a more than six-year low, nearing the RBI's comfort zone. The 30-share BSE Sensex climbed 317.45 points or 0.39 per cent to settle at 82,570.91. During the day, it jumped 490.16 points or 0.59 per cent to 82,743.62. The 50-share NSE Nifty edged higher by 113.50 points or 0.45 per cent to 25,195.80.
Benchmark stock indices Sensex and Nifty declined on Monday, extending the losing run to the fourth day amid selling in IT shares and foreign fund outflows. The 30-share BSE Sensex dropped by 247.01 points or 0.30 per cent to settle at 82,253.46. During the day, it fell 490.09 points or 0.59 per cent to 82,010.38 but recovered some of the losses towards the close.
Given the strong prospects in the business, analysts expect the company to clock healthy growth of 15-20 per cent, going ahead.
'The country is a good test bed for enterprise adoption, but to scale rapidly, companies will need to look outside the country for customers.'
P&G Hygiene and Healthcare's June quarter numbers were better than Street estimates, led by strong sales and robust margins. The company, which owns leading consumer brands like Whisper, Vicks and Old Spice, posted a 12.6 per cent year-on-year (Y-o-Y) growth in sales at Rs 852.5 crore during the quarter. The double digit sales growth, led by expansion of its distribution reach, reverses a sluggish sales graph with three of the last four quarters reporting a fall in sales.
Leading FMCG maker HUL said that it has received a demand notice of Rs 962.75 crore from the Income Tax Department and will go in for an appeal against the order. The notice relates to non-deduction of TDS on payment of Rs 3,045 crore to GlaxoSmithKline Consumer Healthcare (GSKCH) for the acquisition of Intellectual Property Rights of the Health Foods Drinks (HFD) business consisting of brands as Horlicks, Boost, Maltova, and Viva, according to a recent exchange filing.
As per a white paper, 'Aarogya Bharat 2025', India Healthcare Roadmap for next 10 years launched at NATHEALTH event on Tuesday said the country is healthier now than ever before, but its 'continued economic progress is threatened by the country's under-served and under-consumed healthcare system'.
'We continue to view India as a standout within EM.'
If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.
This is the case even though the benchmark index is only 5 per cent below its all-time high. The list of stocks trading at a discount primarily consists companies in the automotive, banking, oil and gas, insurance, healthcare, and metal sectors.
Invest in these funds through the SIP route with at least a seven-year horizon.
Venture capital (VC) and private equity (PE) funds had, in 2024, taken bets on traditional businesses rather than tech-first domains like consumer tech, software as a service (SaaS) and software. According to data from Bain & Co, Pitchbook, Venture Intelligence, VCC Edge and AVCJ, prominent VC funds like PeakXV saw their share in this traditional space go up sharply from 14 per cent in 2023 to 23 per cent in 2024.
Glaxo SmithKline Consumer Healthcare Ltd has posted a net profit of Rs 105.80 million for the quarter ended December 31, 2002 as compared to Rs 303.90 million in the quarter ended December 31, 2001.
Despite recent underperformance, MNC funds have delivered over longer time frames.
Growth in cities has lagged villages as consumers troubled by persistently high inflation have cut spending in the past two years.
Bessemer Venture Partners has closed $350 million in capital for its second dedicated India fund to back founders in the region, who build enduring companies.
US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).
The survey states that while around 71.6 per cent of women believe that social media offers adequate information about menstruation, only 11.5 per cent rely on it as their primary source during menstrual emergencies.
India's e-commerce market alone is projected to reach $200 billion by 2026, making it a prime industry for ambitious entrepreneurs, explains rediffGURU Harsh Bharwani.
rediffGURU Komal Jethmalani, a dietician and nutritionist with over 27 years of experience, tells you how to choose your meals and plan your diet for optimum health benefits.
Dabur's pre-quarterly update for Q3FY25 disappointed the market with the share dropping by 3.9 per cent. Growth was slower than expected and inflation hit margins. The management said that the fast-moving consumer goods (FMCG) consumption in rural markets was resilient and continued to grow faster than in urban markets.
Billionaire Mukesh Ambani's Reliance Industries Ltd has spent $13 billion on acquisitions in the past five years across new energy, telecom, retail and media business to script a pivot away from core oil and petrochemicals business to clean energy and consumer facing verticals. Last week, Reliance bought oncology platform Karkinos Healthcare for Rs 375 crore, adding another stack to its diagnostic and digital healthcare ecosystem, Morgan Stanley said in a report.
The two companies agreed to form a joint venture by combining Novartis' over-the-counter division with GSK's consumer business to create a business with $10 billion in annual sales. GSK will hold a 63.5 per cent stake in the venture.
Analysts expect Nifty to rise up by to 6 per cent in six months, with intermittent corrections likely due to global factors.
Foreign brokerages remain cautious on the road ahead for the Indian equity markets. Though analysts at Nomura have revised their March 2026 Nifty target to 26,140 levels from the earlier 24,970, but the upside from the current levels is a modest 6 per cent. BofA Securities, on the other hand, has not made any change to its year-end Nifty target.
All Sensex firms, except Power Grid, ended in the positive territory. Titan, Bajaj Finance, State Bank of India, Larsen & Toubro, Axis Bank, Bajaj Finserv, Asian Paints and Zomato were the biggest gainers.
From the Sensex pack, Infosys, Tech Mahindra, Nestle India, Tata Consultancy Services, HCL Technologies, Asian Paints, Axis Bank, Zomato, Hindustan Unilever, and Bharti Airtel were among the laggards. On the other hand, IndusInd Bank, Tata Motors, Kotak Mahindra Bank, Bajaj Finance, HDFC Bank, ITC, Sun Pharma, Bajaj Finserv and UltraTech Cement were the gainers.
Investors should tilt their portfolios towards domestic-facing defensive sectors, which should help provide stability and shield them from geopolitical and tariff risks.
The company is increasing its exposure to key emerging markets.
'Many global investors have been overweight on dollar assets, so some diversification or hedging is naturally expected.'
rediffGURU Dr Shakeeb Ahmed Khan, a physiotherapist with 13 years of experience, explains how you can prevent injuries and heal from physical pain.
In 2025, India's tech job market is thriving, with tech professionals seeing a 9.5% salary increase and roles like AI/ML architects earning up to Rs 95 lakh annually.
The cumulative wealth of 284 Indian billionaires is a third of the country's GDP, a report said on Thursday.
India and the US are expected to have smooth trade negotiations after US President Donald Trump and Indian Prime Minister Narendra Modi had a productive meeting during Modi's visit to the White House last month, Stephen A Schwarzman, chairman, chief executive officer, and co-founder of one of the world's largest alternative investment firms, Blackstone Group, said in Mumbai on Wednesday.
